Abiomed Invests In Long-Term LVAD Support With WorldHeart
This article was originally published in The Gray Sheet
Executive Summary
Abiomed is diversifying its ventricular assist device holdings with a $5 million strategic investment in WorldHeart, announced Dec. 12